Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Drugmaker expands manufacturing of popular prostate PET imaging agent
The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.
University launches clinical trial for groundbreaking nuclear medicine cancer treatment
The University of Missouri Research Reactor will play a key role in the trial, as it is the only domestic producer of Y-90.
Photon-counting CT offers numerous benefits in lung cancer imaging
Compared to conventional contrast-enhanced chest computed tomography, photon-counting CT exams can reduce patients' effective radiation dose by more than 66%.
Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.
New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers
Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

Drugmaker expands manufacturing of popular prostate PET imaging agent

The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.

University launches clinical trial for groundbreaking nuclear medicine cancer treatment

The University of Missouri Research Reactor will play a key role in the trial, as it is the only domestic producer of Y-90.

Photon-counting CT scans best conventional CTs for lung cancer follow-up

Photon-counting CT offers numerous benefits in lung cancer imaging

Compared to conventional contrast-enhanced chest computed tomography, photon-counting CT exams can reduce patients' effective radiation dose by more than 66%.

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection

Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.

Novel theranostic shows promise for treating gastric and pancreatic cancer

New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers

Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

Cencora to buy nationwide oncology network in $5B deal

The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."

American College of Cardiology highlights the cardiovascular risks of various cancer treatments

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.